RECRUITING

Multi-Center Project: Building Electronic Tools To Enhance and Reinforce CArdiovascular REcommendations - Heart Failure

Description

This study will test an automated, electronic health record (EHR-)embedded alert to improve prescribing of guideline-directed medical therapy for patients with heart failure and reduced ejection fraction (HFrEF). The investigators have previously tested and implemented this alert at NYU Langone Health (NYULH), and will now test and implement this alert across three other health systems.

Conditions

Heart Failure
Talk to us

Related Conditions:

Heart Failure

Study Overview

On this page

Study Details

Study overview

This study will test an automated, electronic health record (EHR-)embedded alert to improve prescribing of guideline-directed medical therapy for patients with heart failure and reduced ejection fraction (HFrEF). The investigators have previously tested and implemented this alert at NYU Langone Health (NYULH), and will now test and implement this alert across three other health systems.

Multi-Center Project: BETTER CARE - HF (Building Electronic Tools To Enhance and Reinforce CArdiovascular REcommendations - Heart Failure)

Multi-Center Project: Building Electronic Tools To Enhance and Reinforce CArdiovascular REcommendations - Heart Failure

Condition
Heart Failure
Intervention / Treatment

-

Contacts and Locations

Boston

University of Massachusetts, Boston, Massachusetts, United States, 01003

New York

NYU Langone Health, New York, New York, United States, 10016

Columbus

OhioHealth, Columbus, Ohio, United States, 43228

Philadelphia

University of Pennsylvania, Philadelphia, Pennsylvania, United States, 19104

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Patient with an encounter visit at participating cardiology practice during the study period
  • * Patient with EF of less than or equal to 40% on most recent echocardiogram at the time of visit
  • * Patient ages 18-90
  • * Pregnancy
  • * Ventricular assist device
  • * Hospice
  • * Cardiac amyloid
  • * Medication-specific exclusion for MRA: most recent systolic blood pressure less than 105 mm Hg, most recent potassium \< 5.1, any potassium \> 5.5, most recent glomerular filtration rate \< 30 (using MDRD equation), or a documented MRA allergy.

Ages Eligible for Study

18 Years to 90 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

NYU Langone Health,

Amrita Mukhopadhyay, PRINCIPAL_INVESTIGATOR, NYU Langone Health

Study Record Dates

2025-12-31